Drugs that contain Alpelisib

1. List of Piqray drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8476268 NOVARTIS Pyrrolidine-1,2-dicarboxamide derivatives
Sep, 2029

(6 years from now)

US8227462 NOVARTIS Pyrrolidine-1,2-dicarboxamide derivatives
Sep, 2030

(7 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) May 24, 2024

NCE-1 date: 2023-05-25

Market Authorisation Date: 24 May, 2019

Treatment: In combination with fulvestrant for treatment of postmenopausal women, and men, with hr-positive, her-2-negative, pik3ca-mutated, advanced or metastatic breast cancer

Dosage: TABLET;ORAL

More Information on Dosage

PIQRAY family patents

5

United States

3

European Union

2

Hungary

2

Argentina

2

Cyprus

1

Israel

1

South Africa

1

Denmark

1

El Salvador

1

Mexico

1

Australia

1

Jordan

1

Slovenia

1

Lithuania

1

Hong Kong

1

Morocco

1

Uruguay

1

Norway

1

Costa Rica

1

Cuba

1

Colombia

1

Brazil

1

Honduras

1

Croatia

1

Portugal

1

Malaysia

1

Spain

1

Netherlands

1

Dominican Republic

1

Korea, Republic of

1

Poland

1

San Marino

1

Peru

1

Chile

1

RS

1

Taiwan, Province of China

1

China

1

Ecuador

1

Georgia

1

Nicaragua

1

Ukraine

1

Japan

EA

1

EA

1

Canada

1

Tunisia

1

Panama

1

New Zealand

1

ME

2. List of Vijoice drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8476268 NOVARTIS Pyrrolidine-1,2-dicarboxamide derivatives
Sep, 2029

(6 years from now)

US8227462 NOVARTIS Pyrrolidine-1,2-dicarboxamide derivatives
Sep, 2030

(7 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) May 24, 2024
Orphan Drug Exclusivity (ODE) Apr 5, 2029

NCE-1 date: 2023-05-25

Market Authorisation Date: 05 April, 2022

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage

VIJOICE family patents

5

United States

3

European Union

2

Hungary

2

Argentina

2

Cyprus

1

Israel

1

South Africa

1

Denmark

1

El Salvador

1

Mexico

1

Australia

1

Jordan

1

Slovenia

1

Lithuania

1

Hong Kong

1

Morocco

1

Uruguay

1

Norway

1

Costa Rica

1

Cuba

1

Colombia

1

Brazil

1

Honduras

1

Croatia

1

Portugal

1

Malaysia

1

Spain

1

Netherlands

1

Dominican Republic

1

Korea, Republic of

1

Poland

1

San Marino

1

Peru

1

Chile

1

RS

1

Taiwan, Province of China

1

China

1

Ecuador

1

Georgia

1

Nicaragua

1

Ukraine

1

Japan

EA

1

EA

1

Canada

1

Tunisia

1

Panama

1

New Zealand

1

ME

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in